Psycho-Oncology Co-operative Research Group (PoCoG), School of Psychology, University of Sydney, NSW 2006, Australia.
Psycho-Oncology Co-operative Research Group (PoCoG), School of Psychology, University of Sydney, NSW 2006, Australia.
Patient Educ Couns. 2023 Jun;111:107680. doi: 10.1016/j.pec.2023.107680. Epub 2023 Feb 24.
Vaccination is a key strategy to limit the impact of the COVID-19 pandemic, among vulnerable groups such as cancer patients. However, COVID-19 vaccine hesitancy is limiting vaccination uptake in this population as in others. This study aimed to synthesise the emerging literature on vaccine hesitancy in this population and in Oncology health professionals, reasons for and factors associated with hesitancy, and interventions that address hesitancy.
A rapid review was undertaken PubMed, Ovid and Google across all years up to October 2021 for articles in English, from any country or region, addressing the above issues. Individual case studies, opinion pieces, commentary articles and conference abstracts were excluded. Article screening, data extraction and bias assessment were conducted by two authors. A narrative synthesis of the data was undertaken.
Eighteen eligible articles were identified. Reported COVID-19 vaccine hesitancy rates varied from 76.7 % to 3.9 %, with a mean of 38.4 %. A large international study (n > 20,000) reported a more conservative hesitancy rate of 19 %. Six broad, common reasons for hesitancy were identified. Oncologist advice was valued by patients.
Vaccine hesitancy remains a significant concern in the oncology context. Oncologists are key to addressing hesitancy and providing tailored advice to cancer patients.
Where possible, patients appreciate personalised, tailored information about vaccination which addresses its interaction with cancer and its treatment. Education programmes for oncologists to support effective communication in this context are needed. Webinars and peer-to-peer counselling may be useful but remain to be proven.
疫苗接种是限制 COVID-19 大流行对癌症等弱势群体影响的关键策略。然而，COVID-19 疫苗犹豫情绪在限制该人群以及其他人群的疫苗接种率。本研究旨在综合该人群和肿瘤学专业卫生保健人员中疫苗犹豫情绪的现有文献，包括犹豫情绪的原因和相关因素，以及针对犹豫情绪的干预措施。
我们对 PubMed、Ovid 和 Google 进行了快速检索，检索时间截至 2021 年 10 月，检索语言为英语，检索对象为所有国家或地区发表的关于上述问题的文章。排除了单独的病例研究、观点文章、评论文章和会议摘要。两名作者进行了文章筛选、数据提取和偏倚评估。对数据进行了叙述性综合。
共确定了 18 篇合格的文章。报告的 COVID-19 疫苗犹豫率从 76.7%到 3.9%不等，平均为 38.4%。一项大型国际研究（n>20000）报告了一个更为保守的犹豫率 19%。确定了六个常见的普遍犹豫原因。患者重视肿瘤医生的建议。
疫苗犹豫仍然是肿瘤学领域的一个重大问题。肿瘤医生是解决犹豫情绪并为癌症患者提供个性化建议的关键。
在可能的情况下，患者希望获得关于疫苗接种的个性化、定制信息，以了解疫苗接种与癌症及其治疗的相互作用。需要为肿瘤医生提供教育计划，以支持在这种情况下进行有效的沟通。网络研讨会和同行咨询可能有用，但仍有待证明。
